CX3C chemokine fractalkine in pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 10, 2002, Pages 1419-1425

  Balabanian, Karl ^a,b   Foussat, Arnaud ^a,b   Dorfmüller, Peter ^a,b   Durand Gasselin, Ingrid ^a,b   Capel, Francis ^a,b   Bouchet Delbos, Laurence ^a,b   Portier, Alain ^a,b   Marfaing Koka, Anne ^a,b   Krzysiek, Roman ^a,b   Rimaniol, Anne Cécile ^a,b   Simonneau, Gérald ^a,b   Emilie, Dominique ^a,b   Humbert, Marc ^a,b,c  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Chemokines; Endothelium derived factors; Fractalkine; Pulmonary hypertension; Receptors

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CX3C CHEMOKINE; FRACTALKINE; MESSENGER RNA; AUTACOID; CHEMOKINE (C X3 C MOTIF) LIGAND 1; CHEMOKINE (C-X3-C MOTIF) LIGAND 1; MEMBRANE PROTEIN;

ADULT; AGED; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; CASE CONTROL STUDY; CELL CULTURE; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOLOGY; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; NONPARAMETRIC TEST; PATHOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM;

ADULT; AGED; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINES, CX3C; COHORT STUDIES; COMPARATIVE STUDY; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION MEDIATORS; MALE; MEMBRANE PROTEINS; MIDDLE AGE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTE SUBSETS; HUMANS; MIDDLE AGED;

EID: 0037092565     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2106007     Document Type: Article

References (54)

1. Primary pulmonary hypertension
2. Primary pulmonary hypertension: A vascular biology and translational research "work in progress"
3. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension
4. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
5. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline
6. Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1
7. Risk factors for pulmonary arterial hypertension
8. Pulmonary hypertension in POEMS syndrome: A new feature mediated by cytokines
9. Autoantibodies in patients with primary pulmonary hypertension: Association with anti-Ku
10. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension
11. Platelet-derived growth factor expression in primary pulmonary hypertension: Comparison of HIV seropositive and HIV seronegative patients
12. Chemokine MIP-1α expression in lung biopsies of primary pulmonary hypertension
13. Treatment of pulmonary hypertension secondary to connective tissue diseases
14. Effective immunosuppressive therapy in a patient with primary pulmonary hypertension
15. Exuberant endothelial cell growth and element of inflammation are present in plexiform lesions of pulmonary hypertension
16. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
17. Chemokines: A new classification system and their role in immunity
18. 3C motif
19. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation
20. Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart
21. Fractalkine receptor expression by T-lymphocyte subpopulations and in vivo production of fractalkine in human
22. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia
23. The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo
24. Neuronal fractalkine expression in HIV-1 encephalitis: Roles for macrophage recruitment and neuroprotection in the central nervous system
25. Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients
26. 3CR1, which mediates both leukocyte migration and adhesion
27. Identification of CX3CR1
28. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin
29. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses
30. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction
31. 3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow
32. 3CR1
33. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease
34. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
35. Acute upregulation of CCR-5 expression by CD4+ T-lymphocytes in HIV-infected patients treated with interleukin-2: ANRS 048 IL-2 Study Group
36. Quantification of cytokine gene expression by competitive PCR using a colorimetric assay
37. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines
38. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions
39. Cellular localization of fractalkine at sites of inflammation: Antigen-presenting cells in psoriasis express high levels of fractalkine
40. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis
41. Upregulation of fractalkine in human crescentic glomerulonephritis
42. 3R1) in cardiac allograft rejection
43. Endothelium dysfunction in severe pulmonary arterial hypertension: Elevated plasma and pulmonary vascular adhesion molecules
44. Chemokine RANTES in severe pulmonary arterial hypertension
45. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES
46. TACE (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)
47. CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms
48. Unique role of the chemokine domain of fractalkine in cell capture
49. Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation
50. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
51. Endothelial dysfunction in pulmonary hypertension
52. Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension
53. Generation and analysis of mice lacking the chemokine fractalkine
54. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion